Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Curr Oncol. 2024 Aug 16;31(8):4685-4694. doi: 10.3390/curroncol31080349.
Frailty, rather than age, is associated with postoperative morbidity and mortality. We sought to determine whether preoperative frailty as defined by a novel scoring system could predict the outcomes among older patients undergoing esophagectomy. We identified patients 65 years or older who underwent esophagectomy between 2011 and 2021 at our institution. Frailty was assessed using the MSK-FI, which consists of 1 component related to functional status and 10 medical comorbidities. We used a multivariable logistic regression model to test for the associations between frailty and short-term outcomes, with continuous frailty score as the predictor and additionally adjusted for age and Eastern Cooperative Oncology Group performance status. In total, 447 patients were included in the analysis (median age of 71 years [interquartile range, 68-75]). Most of the patients underwent neoadjuvant treatment (81%), an Ivor Lewis esophagectomy (86%), and minimally invasive surgery (55%). A total of 22 patients (4.9%) died within 90 days of surgery, 144 (32%) had a major complication, 81 (19%) were readmitted, and 31 (7.2%) were discharged to a facility. Of the patients who died within 90 days, 19 had a major complication, yielding a failure-to-rescue rate of 13%. The risk of 30-day major complications (OR, 1.24 [95% CI, 1.09-1.41]; = 0.001), readmissions (OR, 1.31 [95% CI, 1.13-1.52]; < 0.001), and discharge to a facility (OR, 1.86 [95% CI, 1.49-2.37]; < 0.001) increased with increasing frailty. Frailty and 90-day mortality were not associated. Frailty assessment during surgery decision-making can identify patients with a high risk of morbidity.
虚弱,而不是年龄,与术后发病率和死亡率相关。我们试图确定术前通过一种新的评分系统定义的虚弱是否可以预测接受食管切除术的老年患者的结果。我们确定了 2011 年至 2021 年在我们机构接受食管切除术的 65 岁或以上的患者。使用 MSK-FI 评估虚弱程度,该评分由 1 个与功能状态相关的组成部分和 10 个医学合并症组成。我们使用多变量逻辑回归模型测试虚弱与短期结果之间的关系,以连续虚弱评分作为预测因子,并进一步调整年龄和东部合作肿瘤学组表现状态。总共纳入了 447 名患者进行分析(中位年龄 71 岁[四分位距,68-75])。大多数患者接受了新辅助治疗(81%)、Ivor Lewis 食管切除术(86%)和微创手术(55%)。共有 22 名患者(4.9%)在手术后 90 天内死亡,144 名患者(32%)发生重大并发症,81 名患者(19%)再次入院,31 名患者(7.2%)出院到康复设施。在 90 天内死亡的患者中,有 19 名患者发生了重大并发症,挽救失败率为 13%。30 天内发生重大并发症的风险(OR,1.24[95%CI,1.09-1.41];=0.001)、再次入院(OR,1.31[95%CI,1.13-1.52];<0.001)和出院到康复设施(OR,1.86[95%CI,1.49-2.37];<0.001)随着虚弱程度的增加而增加。虚弱和 90 天死亡率之间没有关联。在手术决策过程中进行虚弱评估可以识别出患有高发病率风险的患者。